
Oncology NEWS International
- Oncology NEWS International Vol 16 No 12
- Volume 16
- Issue 12
Free website offers chemo order forms
Georgia Cancer Specialists (GCS), a large Atlanta-based oncology practice, has made available a free website, ChemoOrders.com, offering chemotherapy protocol order forms.
ATLANTAGeorgia Cancer Specialists (GCS), a large Atlanta-based oncology practice, has made available a free website, ChemoOrders.com, offering chemotherapy protocol order forms.
ChemoOrders.com creates patient-specific chemotherapy orders and supporting documents based on physician- or nurse-entered vital signs and disease parameters, GCS said in a press release. The site is modeled after a disease management system GCS developed and has used in patient care for several years. The protocols are created using established peer-reviewed clinical guidelines.
"Most oncologists practice the same way they have for 20 years, trusting their memories and nurses' support to prescribe and manage treatment," said Bruce Feinberg, MD, GCS president and CEO. "The ever-growing complexity of cancer management makes this approach increasingly risky for both patient and provider." The site also provides print-ready chemotherapy flow sheets, informed consents, and patient education materials. "We want to provide touch-of-a-button access to everything patients and doctors need for successful treatment," Dr. Feinberg said.
Articles in this issue
about 18 years ago
Third-line single-agent cetuximab ups overall survivalabout 18 years ago
Modern multislice CT propels pancreas imaging forwardabout 18 years ago
Sorafenib gets ok for liver cancerabout 18 years ago
Celgene to acquire Pharmionabout 18 years ago
Novacea halts ASCENT-2 trialabout 18 years ago
RT/temozolomide raises possibility of cure in glioblastomaabout 18 years ago
Brachytherapy as effective in younger as in older menabout 18 years ago
MMA not harming patientsabout 18 years ago
Kinase inhibitor may prevent RT-induced lung injuryabout 18 years ago
FDA approves lower starting dose for dasatinib for CMLNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.

















































































